English
中文
HOME
ABOUT US
COMPANY PROFILE
ENTERPRISE VISION
JOIN US
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
MOST RECOMMENDED
QUALITY & COMPLIANCE
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
CONTACT US
Home >
NEWS
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
Molnupiravir FDA Approval Status
Molnupiravir (EIDD-2801/MK-4482) is an investigational, orally bioavailable form of a potent ribonucleoside analog in development for the treatment of COVID-19.1.Molnupiravir works as an antiviral agent by inhibiting the replication of the SARS-CoV-2 virus, th..
2021-10-25
COVID-19 tracker: CureVac sees hope for vaccine despite trial flop; AZ jab highly protective against death in older adults
CureVac said its vaccine, only 48% effective in late-stage clinical trials, could still pose a "strong public health value."Two doses of AstraZeneca's vaccine prevent roughly 94% of deaths in older people, according to Public Health England.The w..
2021-07-02
Getting to know our products 2021
Currently, Senova is focusing on anti-covid drugs materials such asRemdesivir / Favipiravir / Molnupiravir / Baricitinib and related intermediates, feel free to contact our email sales@senovatech.com for more details. Thanks and wish all are fine despite of..
2021-06-29
2020's party
We were having a league construction activity for celebrating that our company has got to a new point. We chose a hot spring hotel, since we were supposed to stay in GuangZhou Province because of COVID-19. We want to show you that our company is such a lovely ..
2021-02-03
The review of Senova at the CPhI exhibition in Shanghai in 2020
We firstly want to send the greatest congratulations for the successful and promising outcomes from CPhl exhibition 2020. We want to say thank you to everyone here, for your effort and confidence you’ve shown on us, given 2020 is already a tough year fo..
2020-12-29
SENOVA INVITATION LETTER FOR CPhI CHINA 2020
This is an invitation letter for anyone interested in CPhI China.CPhI China 2020 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. CPhI China is your ONE-STOP SHOP pharmaceutical platform in Asia.We hereby sin..
2020-12-04
First
Previous
current 1/9 page
total 51 records
per page 6 Article
1
2
3
Next
End
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
NEWS
COMPANY NEWS
INDUSTRY NEWS
STATEMENT!!!
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: 510# in Building 8 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055 Tel:
+86-0755-8670 3119
QQ: 530953397 Email:
info@senovatech.com